$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$1.12B
Market Cap
-
P/E Ratio
-1.31
EPS
$30.35
52 Week High
$2.82
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Nanobiotix SA is a pioneering clinical-stage biotechnology company based in Paris, France, specializing in the development of groundbreaking cancer therapies utilizing its proprietary nanotechnology platform. Committed to improving treatment efficacy and minimizing side effects, the company is advancing a robust pipeline of localized therapies across multiple clinical trial stages. With its innovative approach and strategic partnerships, Nanobiotix is poised to redefine oncology treatment paradigms and enhance patient outcomes on a global scale, positioning itself as a significant player in the fight against cancer.
LPTX
CGC
NVDA
WOK
PLUG
ASST
TSLA
KIND
AVGO
TLRY
KAVL
INTC
TNYA
ADAP
ORCL
SOFI
PLTD
DNN
F
RR
APLT
PFE
PLTR
AAL
IRBT
BYND
WULF
NFLX
MARA
ASBP
BITF
IREN
MTSR
RKLB
KVUE
FI
AMD
HOOD
QBTS
SNAP
BAC
VALE
CIFR
T
IVP
WBD
GOOGL
GRAB
SOUN
CLSK
SMR
BTBT
NOK
CAN
HPE
CDE
NIO
RIG
DVLT
CMG
MU
APLD
HL
AG
IBRX
LPTX
CGC
NVDA
WOK
PLUG
ASST
TSLA
KIND
AVGO
TLRY
KAVL
INTC
TNYA
ADAP
ORCL
SOFI
PLTD
DNN
F
RR
APLT
PFE
PLTR
AAL
IRBT
BYND
WULF
NFLX
MARA
ASBP
BITF
IREN
MTSR
RKLB
KVUE
FI
AMD
HOOD
QBTS
SNAP
BAC
VALE
CIFR
T
IVP
WBD
GOOGL
GRAB
SOUN
CLSK
SMR
BTBT
NOK
CAN
HPE
CDE
NIO
RIG
DVLT
CMG
MU
APLD
HL
AG
IBRX